All In MedTech

Device Trial Radar · NCT07435298

Navigated Repetitive TMS for Chronic Tinnitus

Neuronavigated Transcranial Magnetic Stimulation As An Adjunctive Treatment For Chronic Tinnitus

Last checked: Nov 19, 2026Latest source record: Sep 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Suspended

Status

Suspended

Enrollment

50

Planned (sponsor's estimate)

Start

Nov 1, 2025

Primary completion

Oct 30, 2027

Study completion Oct 30, 2027

Sponsor

Lead sponsor
National University Hospital, SingaporeAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Alexandra Hospital
First posted
Feb 27, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 21 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is testing whether a special type of brain stimulation called neuronavigated TMS can help reduce tinnitus (ringing in the ears). 50 people with tinnitus will each receive 20 treatment sessions - 10 real treatments and 10 sham treatments in random order, with a 2-week break between them. Before starting, participants get an MRI brain scan to guide where the stimulation device is placed. Questionnaires of measuring tinnitus severity will be asked four times throughout the study to determine to check the effect of TMS on treating tinnitus.

Conditions

  • Tinnitus

Interventions

  • navigated rTMSDevice

    Each session of rTMS (real or sham) consists of 1200 stimulations/day, conducted at once a day for five consecutive days (from Monday to Friday). For sham stimulation, the TMS coil will still centre on the same scalp position, but it was tilted to 90° so that scalp contact and discharging noise were similar, but the magnetic field did not reach cortical neurons at a biologically active level. The localization of the rTMS stimulation site (left Temporal Cortex) will be directed by a neuronavigation system imported with subject's MRI scan imaging to ensure the accuracy of rTMS stimulation area.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Tinnitus Handicap Inventory (THI)Time frame: Week 0
  2. Tinnitus Handicap Inventory (THI)Time frame: Week 3
  3. Tinnitus Handicap Inventory (THI)Time frame: Week 6

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Alexandra Hospital

    Singapore, Singapore

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.